US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

COMPASS Pathways plc

4.35

+0.410010.41%

Post-market: 4.34-0.0100-0.23%19:56 EDT

Volume:6.09M

Turnover:26.55M

Market Cap:406.99M

PE:-2.24

High:4.78

Open:4.02

Low:3.92

Close:3.94

Loading ...

Overview Company News Filings

H.C. Wainwright Keeps Their Buy Rating on COMPASS Pathways (CMPS)

BRIEF-Compass Pathways Establishes Strategic Collaboration With Healthport

Compass Pathways Establishes Strategic Collaboration with HealthPort to Inform the Potential Delivery of COMP360 Synthesized Psilocybin Treatment in Underserved Communities

Compass Pathways to Announce First Quarter Financial Results on May 8, 2025

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

Market Exclusive

Psychedelic: Clearmind completes clinical site initiations for AUD trial

Compass Pathways completes dosing in Part A of Phase 3 psilocybin trial

BRIEF-Compass Pathways Announces Dosing Complete For All Participants In Part A Of Phase 3 Comp005 Trial Of Comp360 Psilocybin

Compass Pathways Announces Dosing Complete for All Participants in Part A of Phase 3 COMP005 Trial of COMP360 Psilocybin for Treatment-Resistant Depression

BUZZ-U.S. STOCKS ON THE MOVE-Dow, Nike, Coty

BUZZ-Jefferies says J&J's depression drug sales bode well for psychedelics

BRIEF-Compass Pathways Announces Completion Of Recruitment For The Phase 3 COMP005 Trial Of COMP360 Psilocybin For Treatment-Resistant Depression

Compass Pathways Announces Completion of Recruitment for the Phase 3 COMP005 Trial of COMP360 Psilocybin for Treatment-Resistant Depression

Psychedelic: Exclusive talk with biotech company Clearmind Medicine

Compass Pathways announces published study on psilocybin in depression

Psychedelic: atai reports dosing of first patient in Phase 2 VLS-01 trial

Compass Pathways to Participate in Stifel Virtual CNS Forum

Compass Pathways Price Target Maintained With a $45.00/Share by HC Wainwright & Co.

Compass one of the most compelling stories in neuropsych, says H.C. Wainwright

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Ramsay Health Care (OtherRMSYF) and COMPASS Pathways (CMPS)

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/CMPS/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"CMPS","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CMPS\",,,,,undefined,":{"symbol":"CMPS","market":"US","secType":"STK","nameCN":"COMPASS Pathways plc","latestPrice":4.35,"timestamp":1753992000000,"preClose":3.94,"halted":0,"volume":6093726,"hourTrading":{"tag":"盘后","latestPrice":4.34,"preClose":4.35,"latestTime":"19:56 EDT","volume":17297,"amount":74709.4774,"timestamp":1754006195913},"delay":0,"floatShares":65852915,"shares":93561753,"eps":-1.943655,"marketStatus":"Closed","change":0.41,"latestTime":"07-31 16:00:00 EDT","open":4.02,"high":4.78,"low":3.9235,"amount":26546098.5738,"amplitude":0.217386,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.943655,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1754035200000},"marketStatusCode":5,"adr":0,"adrRate":1,"listingDate":1600401600000,"exchange":"NASDAQ","adjPreClose":3.94,"preHourTrading":{"tag":"盘前","latestPrice":4.0798,"preClose":3.94,"latestTime":"09:28 EDT","volume":17882,"amount":71568.82460600001,"timestamp":1753968531630},"postHourTrading":{"tag":"盘后","latestPrice":4.34,"preClose":4.35,"latestTime":"19:56 EDT","volume":17297,"amount":74709.4774,"timestamp":1754006195913},"volumeRatio":3.662019,"optionData":{"bulkOrders":[{"symbol":"CMPS","call":false,"expireDate":1758254400000,"strike":"5.0","timestamp":1753975861435,"price":1.05,"volume":8750,"amount":918750,"type":"-"}]},"impliedVol":2.3349,"impliedVolPercentile":0.908},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CMPS\",,,,,undefined,":{"symbol":"CMPS","floatShares":65852915,"roa":"-32.40%","roe":"-60.62%","lyrEps":-2.298685,"volumeRatio":3.662019,"shares":93561753,"dividePrice":0,"high":4.78,"amplitude":0.217386,"preClose":3.94,"low":3.9235,"week52Low":2.25,"pbRate":"2.08","week52High":8.5367,"institutionHeld":0,"latestPrice":4.35,"eps":-1.943655,"divideRate":0,"volume":6093726,"delay":0,"ttmEps":-1.943655,"open":4.02,"prevYearClose":3.78,"prevWeekClose":4.33,"prevMonthClose":2.8,"prevQuarterClose":2.8,"fiveDayClose":4.37,"twentyDayClose":3.38,"sixtyDayClose":4.04},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CMPS\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2532007900","title":"H.C. Wainwright Keeps Their Buy Rating on COMPASS Pathways (CMPS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2532007900","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532007900?lang=en_us&edition=fundamental","pubTime":"2025-05-01 23:55","pubTimestamp":1746114916,"startTime":"0","endTime":"0","summary":"In a report released today, Patrick Trucchio from H.C. Wainwright reiterated a Buy rating on COMPASS Pathways (CMPS – Research Report), with a pric...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/h-c-wainwright-keeps-their-buy-rating-on-compass-pathways-cmps-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/h-c-wainwright-keeps-their-buy-rating-on-compass-pathways-cmps-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CMPS"],"gpt_icon":0},{"id":"2531789897","title":"BRIEF-Compass Pathways Establishes Strategic Collaboration With Healthport","url":"https://stock-news.laohu8.com/highlight/detail?id=2531789897","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531789897?lang=en_us&edition=fundamental","pubTime":"2025-04-29 19:09","pubTimestamp":1745924981,"startTime":"0","endTime":"0","summary":"BRIEF-Compass Pathways Establishes Strategic Collaboration With HealthportApril 29 (Reuters) - Compass Pathways PLC CMPS.O:COMPASS PATHWAYS ESTABLISHES STRATEGIC COLLABORATION WITH HEALTHPORT TO INFOR","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250429:nTUA6ZSDSC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CMPS","BK4139"],"gpt_icon":0},{"id":"2531752788","title":"Compass Pathways Establishes Strategic Collaboration with HealthPort to Inform the Potential Delivery of COMP360 Synthesized Psilocybin Treatment in Underserved Communities","url":"https://stock-news.laohu8.com/highlight/detail?id=2531752788","media":"Business Wire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531752788?lang=en_us&edition=fundamental","pubTime":"2025-04-29 18:30","pubTimestamp":1745922600,"startTime":"0","endTime":"0","summary":"LONDON & NEW YORK, April 29, 2025----Compass Pathways plc , a biotechnology company dedicated to accelerating patient access to evidence-based innovation announced today it is entering into a strategic collaboration with HealthPort, a multi-site comprehensive community health organization. HealthPort employs an integrated model centered around social determinants of health and this collaboration will help inform the potential delivery of COMP360 synthesized psilocybin treatment in underserved communities, if FDA approved. This agreement with HealthPort expands the set of collaborations that Compass has established representing a broad spectrum of settings where people living with treatment resistant depression  receive their care in the United States.\"We are proud to collaborate with Compass Pathways and to contribute to learning how COMP360 psilocybin treatment may be most effectively delivered to patients in underserved communities, if that treatment receives all necessary approvals ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/compass-pathways-establishes-strategic-collaboration-103000809.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["CMPS","BK4139"],"gpt_icon":0},{"id":"2530847640","title":"Compass Pathways to Announce First Quarter Financial Results on May 8, 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2530847640","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530847640?lang=en_us&edition=fundamental","pubTime":"2025-04-28 18:30","pubTimestamp":1745836200,"startTime":"0","endTime":"0","summary":"LONDON & NEW YORK, April 28, 2025----Compass Pathways plc , a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that it will release financial results for the first quarter ended March 31, 2025, and provide an update on recent developments, on May 8, 2025.Compass management will host a conference call at 8:00 am ET  on May 8, 2025.A live webcast of the call will be available on the Compass Pathways website at: First Quarter 2025 Financial Results. The webcast will be archived for 30 days.Compass is headquartered in London, UK, with offices in New York and San Francisco in the US. We envision a world where mental health means not just the absence of illness but the ability to thrive.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/compass-pathways-announce-first-quarter-103000546.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","CMPS"],"gpt_icon":0},{"id":"2530468901","title":"Weekly Roundup on the Cannabis Sector & Psychedelic Sector","url":"https://stock-news.laohu8.com/highlight/detail?id=2530468901","media":"Market Exclusive","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530468901?lang=en_us&edition=fundamental","pubTime":"2025-04-28 03:31","pubTimestamp":1745782287,"startTime":"0","endTime":"0","summary":"Tilray announced plans to exit New Zealand medical cannabis market to focus on Australia. Village Farms was granted 180-day extension to regain Nasdaq listing requirements. SNDL launched “Rise Rewards” loyalty program to boost customer experience. Simply Solventless celebrated profitability at Humble Grow Co., surpassing projections. Cybin expanded clinical partnerships to accelerate phase 3 trial evaluating CYB003 for depression treatment. Compass Pathways completed dosing in phase 3 trial of COMP360 for treatment-resistant depression. Below is a weekly roundup of what happened this week in the cannabis and psychedelic sectors. In this ever-evolving landscape, we explore the major developments and groundbreaking initiatives happening among companies operating in these industries; from advancements in medical research, therapeutic applications to shifts in legal frameworks and current market trends.The New Zealand medical cannabis sector has faced challenges, particularly high regulato","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/weekly-roundup-cannabis-sector-psychedelic-193127070.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4596","VFF","SNDL","NVIW.SI","USAW.SI","CMPS","NZ20C.NZ",".IXIC","BK4189","BK4557","NQmain","CYBN","TLRY","NZ50G.NZ","BK4547","BK4139","MIRA","QLD","QID","T10G.NZ","BK4007","USJW.SI","MNQmain","SQQQ","ACB","TQQQ","TSYW.SI","PSQ"],"gpt_icon":1},{"id":"2530215933","title":"Psychedelic: Clearmind completes clinical site initiations for AUD trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2530215933","media":"TipRanks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530215933?lang=en_us&edition=fundamental","pubTime":"2025-04-25 23:30","pubTimestamp":1745595026,"startTime":"0","endTime":"0","summary":"In this week’s “Psychedelic,” The Fly’s recurring series focused on psychedelic stock news, The Fly looks back on site initiations, dosing completion and clinical site partnerships.Discover outperforming stocks and invest smarter with Top Smart Score Stocks.Filter, analyze, and streamline your search for investment opportunities using  Tipranks' Stock Screener.“AUD remains one of the most urgent and underserved public health challenges globally,” said Dr. Adi Zuloff-Shani, CEO. “With millions affected and current treatments often falling short, the study initiation for our FDA-approved CMND-100 trial marks a critical step toward potentially transforming the treatment landscape for alcoholism. We are honored to collaborate with world renowned institutions such as Yale and Johns Hopkins as we advance our mission to potentially provide safe, effective, and innovative solutions for individuals those suffering from alcoholism.”“Completing dosing of all participants in Part A of our 005 tria","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/psychedelic-clearmind-completes-clinical-initiations-153026935.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/psychedelic-clearmind-completes-clinical-initiations-153026935.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["DRUG","PBM","BK4547","BK4139","ENVB","ATAI","SNPX","QNTM","BETRF","CYBN","BK4168","MDXXF","ALID","SILO","BK4202","FLHLF","RLMD","CMND","MIRA","MNMD","MYCOF","NRXP","SPRC","AGNPF","BK4539","NUMIF","KTTA","PHRRF","BK4007","PSYGF","CMPS","ENTBF","RVVTF","SEEL","IXHL","GHRS","OPTHF"],"gpt_icon":0},{"id":"2529733793","title":"Compass Pathways completes dosing in Part A of Phase 3 psilocybin trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2529733793","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529733793?lang=en_us&edition=fundamental","pubTime":"2025-04-22 18:10","pubTimestamp":1745316601,"startTime":"0","endTime":"0","summary":"Compass Pathways (CMPS) announced that all participants have completed dosing in Part A of the COMP005 phase 3 trial for treatment resistant depres...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/compass-pathways-completes-dosing-in-part-a-of-phase-3-psilocybin-trial?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/compass-pathways-completes-dosing-in-part-a-of-phase-3-psilocybin-trial?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CMPS","BK4139"],"gpt_icon":0},{"id":"2529202563","title":"BRIEF-Compass Pathways Announces Dosing Complete For All Participants In Part A Of Phase 3 Comp005 Trial Of Comp360 Psilocybin","url":"https://stock-news.laohu8.com/highlight/detail?id=2529202563","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529202563?lang=en_us&edition=fundamental","pubTime":"2025-04-22 18:03","pubTimestamp":1745316226,"startTime":"0","endTime":"0","summary":"BRIEF-Compass Pathways Announces Dosing Complete For All Participants In Part A Of Phase 3 Comp005 Trial Of Comp360 Psilocybin April 22 (Reuters) - Compass Pathways PLC CMPS.O:COMPASS PATHWAYS ANNOUNC","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250422:nTUA39D1GN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CMPS","BK4139"],"gpt_icon":0},{"id":"2529320952","title":"Compass Pathways Announces Dosing Complete for All Participants in Part A of Phase 3 COMP005 Trial of COMP360 Psilocybin for Treatment-Resistant Depression","url":"https://stock-news.laohu8.com/highlight/detail?id=2529320952","media":"Business Wire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529320952?lang=en_us&edition=fundamental","pubTime":"2025-04-22 18:00","pubTimestamp":1745316000,"startTime":"0","endTime":"0","summary":"Participants received a single dose of either 25 mg of COMP360 or placebo. On track for disclosure of top-line 6-week primary endpoint results in late June. \"Completing dosing of all participants in Part A of our 005 trial marks a critical milestone in our mission to address the pressing unmet need in treatment resistant depression,\" said Kabir Nath, CEO Compass Pathways. \"We are proud of this achievement which reflects our team’s commitment to scientific rigor, operational excellence and potential to deliver a new treatment option to patients who have long been underserved. We are incredibly grateful to the participants, investigators and clinical sites that are making this study possible. We look forward to sharing the results of the 6-week primary endpoint in late June.\". Approximately one-third of patients with MDD aren’t helped by existing therapies and are at high risk of developing treatment-resistant depression. TRD is generally defined as an inadequate response to two or more ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/compass-pathways-announces-dosing-complete-100000023.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Compass Pathways Announces Dosing Complete for All Participants in Part A of Phase 3 COMP005 Trial of COMP360 Psilocybin for Treatment-Resistant Depression","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["CMPS","BK4139"],"gpt_icon":0},{"id":"2527425040","title":"BUZZ-U.S. STOCKS ON THE MOVE-Dow, Nike, Coty","url":"https://stock-news.laohu8.com/highlight/detail?id=2527425040","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527425040?lang=en_us&edition=fundamental","pubTime":"2025-04-16 01:53","pubTimestamp":1744739611,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Dow, Nike, CotyEikon search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call newsletter: https://refini.tv/","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250415:nL6N3QT0GU:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CVX","CHD","JNJ","AUR","BK4109","HRL","CMPS","CYTK","FMC","NEM","XOM","LU2468319806.SGD","SPNT","LU1223082519.USD","MTVA","ALB","PEP","SEDG","COTY","EOSE","LU0788108826.HKD","HUN","NKE","BK4108","PNC","HXL","HWM","AMAT","MP","SKYE","CTVA","LU1280957306.USD","HPE","IE00B5949003.HKD","CAT","LU0795875086.SGD","VLO","LU2249611893.SGD","ACI","IE00BBT3K403.USD","FLNC","LVS","RDFN","DOW","ADM"],"gpt_icon":1},{"id":"2527144517","title":"BUZZ-Jefferies says J&J's depression drug sales bode well for psychedelics","url":"https://stock-news.laohu8.com/highlight/detail?id=2527144517","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527144517?lang=en_us&edition=fundamental","pubTime":"2025-04-15 22:40","pubTimestamp":1744728015,"startTime":"0","endTime":"0","summary":"BUZZ-Jefferies says J&J's depression drug sales bode well for psychedelics** Brokerage Jefferies says quarterly sales growth of Spravato, Johnson & Johnson's JNJ.N nasal spray for treatment-resistant depression, bodes well for psychedelic treatments** JNJ reports Q1 sales of $320 million for Spravato, up 41.9% from a year earlier** JNJ's commitment to building out infrastructure by working with hospitals or physicians and marketing the drug should only help facilitate adoption of future psychedelics, says Jefferies** Brokerage says existing players in this space such as Atai Life Sciences 9VC.DE could \"eventually leverage the global infrastructure built by JNJ\"** Atai's depression drug BPL-003 is currently in mid-stage development ** U.S.-listed shares of Atai ATAI.O up 3.3% ** Shares of Compass Pathways CMPS.O, which also has a psychedelic depression treatment in development, climbs 1.7% ** Including session's move, ATAI up 5.3%, CMPS down 18.8% YTD  ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250415:nL4N3QT19S:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CMPS","JNJ"],"gpt_icon":0},{"id":"2522287113","title":"BRIEF-Compass Pathways Announces Completion Of Recruitment For The Phase 3 COMP005 Trial Of COMP360 Psilocybin For Treatment-Resistant Depression","url":"https://stock-news.laohu8.com/highlight/detail?id=2522287113","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522287113?lang=en_us&edition=fundamental","pubTime":"2025-03-26 19:54","pubTimestamp":1742990075,"startTime":"0","endTime":"0","summary":"BRIEF-Compass Pathways Announces Completion Of Recruitment For The Phase 3 COMP005 Trial Of COMP360 Psilocybin For Treatment-Resistant DepressionMarch 26 (Reuters) - Compass Pathways PLC CMPS.O:COMPAS","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250326:nTUA3SD6VQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CMPS","BK4139"],"gpt_icon":0},{"id":"2522830827","title":"Compass Pathways Announces Completion of Recruitment for the Phase 3 COMP005 Trial of COMP360 Psilocybin for Treatment-Resistant Depression","url":"https://stock-news.laohu8.com/highlight/detail?id=2522830827","media":"Business Wire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522830827?lang=en_us&edition=fundamental","pubTime":"2025-03-26 18:30","pubTimestamp":1742985000,"startTime":"0","endTime":"0","summary":"Screening closed for all sites and final participants being scheduled for dosing. On track for top-line 6-week primary endpoint results in late Q2. LONDON & NEW YORK, March 26, 2025----Compass Pathways plc , a biotechnology company dedicated to accelerating patient access to evidence-based innovation, today announced the completion of recruitment in the COMP005 phase 3 trial for treatment resistant depression . The final participants are completing pre-dosing activities, including washout from anti-depressant medications, if necessary, and those eligible will receive a dose of either 25 mg of COMP360 or placebo.TRD is a condition in which individuals with major depressive disorder do not respond adequately to at least two different treatments. Depression is the leading cause of disability and ill health worldwide. Up to two-thirds of people with depression are not helped by the first antidepressant medication they try. Up to a third of people with depression are failed by multiple atte","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/compass-pathways-announces-completion-recruitment-103000306.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Compass Pathways Announces Completion of Recruitment for the Phase 3 COMP005 Trial of COMP360 Psilocybin for Treatment-Resistant Depression","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["CMPS","BK4139"],"gpt_icon":0},{"id":"2521172612","title":"Psychedelic: Exclusive talk with biotech company Clearmind Medicine","url":"https://stock-news.laohu8.com/highlight/detail?id=2521172612","media":"TipRanks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521172612?lang=en_us&edition=fundamental","pubTime":"2025-03-22 22:30","pubTimestamp":1742653811,"startTime":"0","endTime":"0","summary":"In this edition of “Psychedelic”, The Fly conducted an exclusive interview with Mark Haden, vice president of business development at Clearmind Medicine , a psychedelic pharmaceutical biotech company focused on development of therapeutics to solve underserved health problems. Here are some highlights:. Discover stocks' market position with detailed  competitor analyses.“Think of this space as being two overlapping circles, a Venn diagram,” Haden said. “There are addiction treatments, like counseling, Alcoholics Anonymous and some pharmaceutical interventions like Antabuse, naltrexone and acamprosate. I ran an addictions treatment program for 28 years and I can assure you that there is relatively low efficacy, the dropout rate is high, and the treatments tend to be very long-term. That’s the first circle.”“You can take MEAI if you are addicted to alcohol and you don’t want to stop,” Haden said. “You can add MEAI to your alcohol and we believe it will result in people drinking less. It c","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/psychedelic-exclusive-talk-biotech-company-143011967.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/psychedelic-exclusive-talk-biotech-company-143011967.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4007","DRUG","BK4168","KTTA","OPTHF","CMND","MYCOF","ENTBF","GHRS","ALID","PSYGF","SILO","BETRF","MDXXF","BK4547","SNPX","IXHL","CYBN","NUMIF","FLHLF","BK4202","MIRA","RVVTF","ATAI","PBM","AGNPF","BK4139","SPRC","MNMD","BK4539","QNTM","NRXP","RLMD","SEEL","PHRRF","CMPS"],"gpt_icon":0},{"id":"2520964011","title":"Compass Pathways announces published study on psilocybin in depression","url":"https://stock-news.laohu8.com/highlight/detail?id=2520964011","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520964011?lang=en_us&edition=fundamental","pubTime":"2025-03-18 18:35","pubTimestamp":1742294147,"startTime":"0","endTime":"0","summary":"Compass Pathways (CMPS) announced the publication of results from the COMP004 study, an observational 52-week follow-up from the Phase 2 COMP001 an...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/compass-pathways-announces-published-study-on-psilocybin-in-depression?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/compass-pathways-announces-published-study-on-psilocybin-in-depression?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","CMPS"],"gpt_icon":0},{"id":"2519638156","title":"Psychedelic: atai reports dosing of first patient in Phase 2 VLS-01 trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2519638156","media":"TipRanks","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519638156?lang=en_us&edition=fundamental","pubTime":"2025-03-14 23:40","pubTimestamp":1741966809,"startTime":"0","endTime":"0","summary":"In this week’s “Psychedelic,” The Fly’s recurring series focused on psychedelic stock news, The Fly looks back on a dosing initiation, a development expansion and a distribution agreement.Discover stocks' market position with detailed  competitor analyses.MIRA EXPANDS KETAMIR-2 DEVELOPMENT WITH TOPICAL: On Thursday, MIRA Pharmaceuticals  announced the formulation of Ketamir-2 into a topical treatment for localized neuropathic and inflammatory pain. This expands the company’s pain management portfolio beyond its ongoing Ketamir-2 oral treatment for neuropathic pain, offering a novel, targeted approach for localized pain relief. The topical treatment of Ketamir-2 is designed for slow release, delivering targeted pain relief directly at the application site while minimizing systemic exposure and side effects.“The development of both an oral and topical formulation of Ketamir-2 significantly expands our pipeline and enhances the value proposition of MIRA,” stated Erez Aminov, CEO . “By adv","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/psychedelic-atai-reports-dosing-first-154009720.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/psychedelic-atai-reports-dosing-first-154009720.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["ENVB","GHRS","CMPS","MNMD","DRUG","RLMD","BK4547","OPTHF","AGNPF","MDXXF","RVVTF","BK4168","FLHLF","MIRA","BETRF","KTTA","BK4139","CYBN","SEEL","MYCOF","SNPX","NUMIF","QNTM","ATAI","PHRRF","SILO","BK4539","ALID","PBM","PSYGF","CMND","ENTBF","SPRC","NRXP","IXHL","BK4202","BK4007"],"gpt_icon":0},{"id":"2518201745","title":"Compass Pathways to Participate in Stifel Virtual CNS Forum","url":"https://stock-news.laohu8.com/highlight/detail?id=2518201745","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518201745?lang=en_us&edition=fundamental","pubTime":"2025-03-11 18:30","pubTimestamp":1741689000,"startTime":"0","endTime":"0","summary":"LONDON & NEW YORK, March 11, 2025----Compass Pathways plc , a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that management will present at the Stifel Virtual CNS Forum at 11:30 am ET on March 18th, 2025.A live audio webcast of the presentation will be accessible from the \"Events\" page of the Investors section of the Compass website. A replay of the webcast will be accessible for 30 days following each event.Compass Pathways plc  is a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health. We are motivated by the need to find better ways to help and empower people with serious mental health conditions who are not helped by existing treatments. We are pioneering a new paradigm for treating mental health conditions focused on rapid and durable responses through the development of our investigational COMP360 psilocybin treatment, potentially a first in clas","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/compass-pathways-participate-stifel-virtual-103000829.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","BK4127","BK4179","BK4135","CMPS","CNS","FET","SF"],"gpt_icon":0},{"id":"2517604157","title":"Compass Pathways Price Target Maintained With a $45.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2517604157","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517604157?lang=en_us&edition=fundamental","pubTime":"2025-03-05 01:31","pubTimestamp":1741109460,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/CMPS/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 04, 2025 12:31 ET (17:31 GMT)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CMPS"],"gpt_icon":0},{"id":"2517606055","title":"Compass one of the most compelling stories in neuropsych, says H.C. Wainwright","url":"https://stock-news.laohu8.com/highlight/detail?id=2517606055","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517606055?lang=en_us&edition=fundamental","pubTime":"2025-03-05 00:06","pubTimestamp":1741104392,"startTime":"0","endTime":"0","summary":"H.C. Wainwright tells investors in a research note that Compass Pathways (CMPS) is one of the most compelling stories in neuropsychiatry, and that ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/compass-one-of-the-most-compelling-stories-in-neuropsych-says-h-c-wainwright?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/compass-one-of-the-most-compelling-stories-in-neuropsych-says-h-c-wainwright?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","CMPS"],"gpt_icon":0},{"id":"2516692875","title":"Analysts’ Opinions Are Mixed on These Healthcare Stocks: Ramsay Health Care (OtherRMSYF) and COMPASS Pathways (CMPS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2516692875","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516692875?lang=en_us&edition=fundamental","pubTime":"2025-03-04 09:50","pubTimestamp":1741053009,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Ramsay Health Care (RMSYF – Research Report) and C...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-ramsay-health-care-otherrmsyf-and-compass-pathways-cmps?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-ramsay-health-care-otherrmsyf-and-compass-pathways-cmps?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4137","CMPS","BK4139","HCSG"],"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":3,"totalSize":77,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CMPS\",params:#limit:5,,,undefined,":[{"date":"2025-07-31","symbol":"CMPS","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":"2025/06","expectedEps":-0.37,"defaultRemindTime":1753948800000,"name":null,"time":"Pre-Market","dateTimestamp":1753934400000,"actualEps":null},{"market":"US","date":"2025-05-08","symbol":"CMPS","fiscalQuarterEnding":"2025/03","expectedEps":-0.47,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1746676800000,"reportTimeType":"pre","actualEps":-0.44},{"market":"US","date":"2025-02-27","symbol":"CMPS","fiscalQuarterEnding":"2024/12","expectedEps":-0.63,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1740632400000,"reportTimeType":"pre","actualEps":-0.63},{"market":"US","date":"2024-10-31","symbol":"CMPS","fiscalQuarterEnding":"2024/09","expectedEps":-0.6,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1730347200000,"reportTimeType":"pre","actualEps":-0.56},{"market":"US","date":"2024-08-01","symbol":"CMPS","fiscalQuarterEnding":"2024/06","expectedEps":-0.53,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1722484800000,"reportTimeType":"pre","actualEps":-0.56}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CMPS\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"CMPS\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.2222,"buy":0.6667,"hold":0.1111,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6667,"analysts":9,"updateTime":1750737600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/CMPS\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"CMPS","date":"2025-07-30","current":-2.912793,"percent":0.850507,"low":-45.689061,"twenty":-21.757367,"median":-4.996002,"eighty":-3.203658,"high":-1.58914,"avg":-10.635683,"sd":10.668855,"marketCap":401379920},"quantilePoints":[{"date":"2020-09-18","current":-13.976745,"twenty":-45.689061,"median":-45.689061,"eighty":-26.661671,"marketCap":533198843},{"date":"2020-09-25","current":-40.65932,"twenty":-43.677165,"median":-36.887242,"eighty":-29.626949,"marketCap":1551112389},{"date":"2020-10-02","current":-34.678623,"twenty":-39.44246,"median":-34.678623,"eighty":-32.24867,"marketCap":1322954787},{"date":"2020-10-09","current":-32.597152,"twenty":-39.095862,"median":-35.366168,"eighty":-32.706406,"marketCap":1243548755},{"date":"2020-10-16","current":-36.571725,"twenty":-37.707587,"median":-35.884181,"eighty":-32.968238,"marketCap":1395174752},{"date":"2020-10-23","current":-36.157315,"twenty":-37.48908,"median":-35.738196,"eighty":-32.968238,"marketCap":1379365407},{"date":"2020-10-30","current":-30.138944,"twenty":-37.006856,"median":-34.688041,"eighty":-32.365459,"marketCap":1149770592},{"date":"2020-11-06","current":-36.458704,"twenty":-37.006856,"median":-34.683332,"eighty":-31.984955,"marketCap":1390863113},{"date":"2020-11-13","current":-26.112945,"twenty":-36.567958,"median":-34.612694,"eighty":-31.45564,"marketCap":1283790726},{"date":"2020-11-20","current":-24.724348,"twenty":-36.520866,"median":-33.670852,"eighty":-30.357452,"marketCap":1215523097},{"date":"2020-11-27","current":-34.678401,"twenty":-36.447402,"median":-33.586086,"eighty":-27.776339,"marketCap":1704894205},{"date":"2020-12-04","current":-35.811204,"twenty":-36.451985,"median":-33.717944,"eighty":-29.899976,"marketCap":1760586219},{"date":"2020-12-11","current":-42.279146,"twenty":-37.485312,"median":-34.645547,"eighty":-30.248198,"marketCap":2078569648},{"date":"2020-12-18","current":-41.650623,"twenty":-39.563341,"median":-34.688041,"eighty":-30.728538,"marketCap":2047669563},{"date":"2020-12-24","current":-40.218175,"twenty":-40.072006,"median":-34.951757,"eighty":-30.901836,"marketCap":1977246114},{"date":"2020-12-31","current":-34.81726,"twenty":-40.042772,"median":-35.13883,"eighty":-31.037462,"marketCap":1711720968},{"date":"2021-01-08","current":-33.041317,"twenty":-39.992047,"median":-34.832707,"eighty":-31.176854,"marketCap":1624410264},{"date":"2021-01-15","current":-31.060738,"twenty":-39.743967,"median":-34.678623,"eighty":-31.028958,"marketCap":1527039067},{"date":"2021-01-22","current":-35.314232,"twenty":-39.320702,"median":-34.678401,"eighty":-31.067116,"marketCap":1736153593},{"date":"2021-01-29","current":-32.032756,"twenty":-38.652713,"median":-34.166812,"eighty":-31.150483,"marketCap":1574826407},{"date":"2021-02-05","current":-33.070551,"twenty":-38.008378,"median":-33.750233,"eighty":-31.150483,"marketCap":1625847477},{"date":"2021-02-12","current":-35.628494,"twenty":-37.677448,"median":-33.734088,"eighty":-31.231745,"marketCap":1751603636},{"date":"2021-02-19","current":-38.822268,"twenty":-37.707587,"median":-33.971765,"eighty":-31.271221,"marketCap":1908619182},{"date":"2021-02-26","current":-32.975541,"twenty":-37.707587,"median":-34.239896,"eighty":-31.514854,"marketCap":1621176534},{"date":"2021-03-05","current":-30.022944,"twenty":-37.605161,"median":-34.166812,"eighty":-31.271221,"marketCap":1476017997},{"date":"2021-03-12","current":-25.099979,"twenty":-37.56525,"median":-33.750233,"eighty":-31.060738,"marketCap":1514382163},{"date":"2021-03-19","current":-23.854097,"twenty":-37.513374,"median":-33.586086,"eighty":-30.689255,"marketCap":1439213073},{"date":"2021-03-26","current":-21.119232,"twenty":-37.409676,"median":-33.472513,"eighty":-29.305258,"marketCap":1274207752},{"date":"2021-04-01","current":-22.790538,"twenty":-37.162043,"median":-33.319036,"eighty":-26.966341,"marketCap":1375044337},{"date":"2021-04-09","current":-21.757367,"twenty":-36.612295,"median":-33.126801,"eighty":-26.150949,"marketCap":1312708994},{"date":"2021-04-16","current":-20.876133,"twenty":-36.569841,"median":-33.070551,"eighty":-25.501296,"marketCap":1259540613},{"date":"2021-04-23","current":-21.453493,"twenty":-36.555331,"median":-32.922913,"eighty":-24.907335,"marketCap":1294375069},{"date":"2021-04-30","current":-24.461104,"twenty":-36.517196,"median":-32.836681,"eighty":-24.513753,"marketCap":1475836240},{"date":"2021-05-07","current":-22.964723,"twenty":-36.472756,"median":-32.668588,"eighty":-23.742271,"marketCap":1385553615},{"date":"2021-05-14","current":-23.869791,"twenty":-36.454909,"median":-32.597152,"eighty":-23.704591,"marketCap":1538742239},{"date":"2021-05-21","current":-24.931751,"twenty":-36.436804,"median":-32.295859,"eighty":-23.742271,"marketCap":1607200385},{"date":"2021-05-28","current":-24.08496,"twenty":-36.420527,"median":-32.135074,"eighty":-23.742271,"marketCap":1552612844},{"date":"2021-06-04","current":-23.050764,"twenty":-36.402194,"median":-31.864663,"eighty":-23.591585,"marketCap":1485944454},{"date":"2021-06-11","current":-27.541533,"twenty":-36.157315,"median":-31.568088,"eighty":-23.70216,"marketCap":1775437396},{"date":"2021-06-18","current":-25.223269,"twenty":-36.157315,"median":-31.203226,"eighty":-23.714315,"marketCap":1625992817},{"date":"2021-06-25","current":-23.24511,"twenty":-35.884181,"median":-31.060738,"eighty":-23.591585,"marketCap":1498472742},{"date":"2021-07-02","current":-25.868774,"twenty":-35.811204,"median":-30.761093,"eighty":-23.70216,"marketCap":1667604631},{"date":"2021-07-09","current":-25.438437,"twenty":-35.764099,"median":-30.685213,"eighty":-23.680045,"marketCap":1639863421},{"date":"2021-07-16","current":-24.307069,"twenty":-35.729719,"median":-29.931589,"eighty":-23.711884,"marketCap":1566930887},{"date":"2021-07-23","current":-25.563374,"twenty":-35.647609,"median":-28.875524,"eighty":-23.826141,"marketCap":1647917321},{"date":"2021-07-30","current":-24.626351,"twenty":-35.470632,"median":-27.303776,"eighty":-23.855547,"marketCap":1587513075},{"date":"2021-08-06","current":-23.383928,"twenty":-35.337619,"median":-27.014024,"eighty":-23.584758,"marketCap":1507421519},{"date":"2021-08-13","current":-19.19141,"twenty":-35.249918,"median":-26.671315,"eighty":-23.467987,"marketCap":1261700837},{"date":"2021-08-20","current":-19.445096,"twenty":-35.157832,"median":-26.312992,"eighty":-23.356525,"marketCap":1278378971},{"date":"2021-08-27","current":-20.18713,"twenty":-35.074516,"median":-26.281885,"eighty":-23.2086,"marketCap":1327162513},{"date":"2021-09-03","current":-21.081376,"twenty":-34.973093,"median":-26.112945,"eighty":-22.962497,"marketCap":1385952935},{"date":"2021-09-10","current":-21.823411,"twenty":-34.94999,"median":-25.987291,"eighty":-22.778021,"marketCap":1434736477},{"date":"2021-09-17","current":-21.017955,"twenty":-34.888418,"median":-25.875715,"eighty":-22.699554,"marketCap":1381783401},{"date":"2021-09-24","current":-20.453502,"twenty":-34.838388,"median":-25.806306,"eighty":-22.442906,"marketCap":1344674553},{"date":"2021-10-01","current":-19.597308,"twenty":-34.823107,"median":-25.737074,"eighty":-22.004636,"marketCap":1288385851},{"date":"2021-10-08","current":-19.968535,"twenty":-34.739729,"median":-25.61196,"eighty":-21.803116,"marketCap":1312791411},{"date":"2021-10-15","current":-20.44443,"twenty":-34.68239,"median":-25.456857,"eighty":-21.54501,"marketCap":1344078146},{"date":"2021-10-22","current":-24.676719,"twenty":-34.67849,"median":-25.38291,"eighty":-21.481373,"marketCap":1622321511},{"date":"2021-10-29","current":-26.777,"twenty":-34.638977,"median":-25.356917,"eighty":-21.54501,"marketCap":1760400303},{"date":"2021-11-05","current":-31.066396,"twenty":-34.389015,"median":-25.438437,"eighty":-21.684437,"marketCap":2042398077},{"date":"2021-11-12","current":-22.756733,"twenty":-34.152195,"median":-25.394667,"eighty":-21.684437,"marketCap":1476866460},{"date":"2021-11-19","current":-19.978855,"twenty":-33.947372,"median":-25.223269,"eighty":-21.561591,"marketCap":1296587762},{"date":"2021-11-26","current":-21.059141,"twenty":-33.809974,"median":-25.126096,"eighty":-21.453493,"marketCap":1366696145},{"date":"2021-12-03","current":-19.033605,"twenty":-33.737317,"median":-25.088225,"eighty":-21.244815,"marketCap":1235242928},{"date":"2021-12-10","current":-16.29431,"twenty":-33.68027,"median":-24.987278,"eighty":-21.103242,"marketCap":1057468101},{"date":"2021-12-17","current":-15.078988,"twenty":-33.593621,"median":-24.900517,"eighty":-21.002734,"marketCap":978596171},{"date":"2021-12-23","current":-15.291187,"twenty":-33.546529,"median":-24.862218,"eighty":-20.943117,"marketCap":992367460},{"date":"2021-12-31","current":-14.210901,"twenty":-33.525698,"median":-24.80474,"eighty":-20.740397,"marketCap":922259078},{"date":"2022-01-07","current":-12.133923,"twenty":-33.449126,"median":-24.700122,"eighty":-20.610827,"marketCap":787467366},{"date":"2022-01-14","current":-11.510187,"twenty":-33.34827,"median":-24.461104,"eighty":-20.502075,"marketCap":746988122},{"date":"2022-01-21","current":-10.140539,"twenty":-33.319036,"median":-24.355655,"eighty":-20.44443,"marketCap":658100708},{"date":"2022-01-28","current":-9.503942,"twenty":-33.256442,"median":-24.307881,"eighty":-20.218841,"marketCap":616786840},{"date":"2022-02-04","current":-9.548954,"twenty":-33.129018,"median":-24.23766,"eighty":-20.053945,"marketCap":619708023},{"date":"2022-02-11","current":-9.645408,"twenty":-33.124584,"median":-24.212577,"eighty":-19.927101,"marketCap":625967700},{"date":"2022-02-18","current":-8.590844,"twenty":-33.115165,"median":-24.1106,"eighty":-19.727415,"marketCap":557528564},{"date":"2022-02-25","current":-8.012487,"twenty":-33.079474,"median":-23.982532,"eighty":-19.536424,"marketCap":574831876},{"date":"2022-03-04","current":-7.280352,"twenty":-33.047164,"median":-23.93226,"eighty":-19.272589,"marketCap":522307033},{"date":"2022-03-11","current":-7.116354,"twenty":-32.988696,"median":-23.85591,"eighty":-19.0533,"marketCap":510541469},{"date":"2022-03-18","current":-7.936345,"twenty":-32.891337,"median":-23.708237,"eighty":-18.918696,"marketCap":569369292},{"date":"2022-03-25","current":-7.333066,"twenty":-32.860943,"median":-23.557451,"eighty":-18.345443,"marketCap":526088822},{"date":"2022-04-01","current":-7.830918,"twenty":-32.841066,"median":-23.48232,"eighty":-16.214575,"marketCap":561805715},{"date":"2022-04-08","current":-7.321352,"twenty":-32.772367,"median":-23.383928,"eighty":-15.288615,"marketCap":525248425},{"date":"2022-04-14","current":-7.379923,"twenty":-32.712439,"median":-23.361821,"eighty":-14.973532,"marketCap":529450412},{"date":"2022-04-22","current":-7.38578,"twenty":-32.665665,"median":-23.265932,"eighty":-14.437247,"marketCap":529870611},{"date":"2022-04-29","current":-5.368583,"twenty":-32.623276,"median":-23.203464,"eighty":-14.005352,"marketCap":385152894},{"date":"2022-05-06","current":-4.918238,"twenty":-32.599416,"median":-23.040353,"eighty":-12.739655,"marketCap":352844263},{"date":"2022-05-13","current":-4.04451,"twenty":-32.552313,"median":-22.953591,"eighty":-11.622074,"marketCap":324361653},{"date":"2022-05-20","current":-4.431469,"twenty":-32.399638,"median":-22.774892,"eighty":-10.679396,"marketCap":355394944},{"date":"2022-05-27","current":-4.457973,"twenty":-32.291474,"median":-22.754073,"eighty":-10.112246,"marketCap":357520512},{"date":"2022-06-03","current":-4.897939,"twenty":-32.248759,"median":-22.724541,"eighty":-9.919338,"marketCap":392804938},{"date":"2022-06-10","current":-4.866135,"twenty":-32.180628,"median":-22.625298,"eighty":-9.678846,"marketCap":390254257},{"date":"2022-06-17","current":-5.263695,"twenty":-32.094147,"median":-22.486664,"eighty":-9.506514,"marketCap":422137775},{"date":"2022-06-24","current":-5.69836,"twenty":-31.999137,"median":-22.405115,"eighty":-9.329038,"marketCap":456997087},{"date":"2022-07-01","current":-5.724864,"twenty":-31.858816,"median":-22.246546,"eighty":-8.568611,"marketCap":459122655},{"date":"2022-07-08","current":-7.214389,"twenty":-31.835429,"median":-22.097706,"eighty":-8.305342,"marketCap":578579568},{"date":"2022-07-15","current":-6.408667,"twenty":-31.83426,"median":-21.914367,"eighty":-8.030059,"marketCap":513962306},{"date":"2022-07-22","current":-7.691461,"twenty":-31.301916,"median":-21.839413,"eighty":-7.877775,"marketCap":616839790},{"date":"2022-07-29","current":-8.263947,"twenty":-31.250757,"median":-21.772673,"eighty":-7.903493,"marketCap":662752055},{"date":"2022-08-05","current":-10.195378,"twenty":-31.203226,"median":-21.666205,"eighty":-7.919395,"marketCap":853424507},{"date":"2022-08-12","current":-9.324174,"twenty":-31.071368,"median":-21.49996,"eighty":-7.936345,"marketCap":780498596},{"date":"2022-08-19","current":-8.011017,"twenty":-31.066396,"median":-21.443891,"eighty":-8.009509,"marketCap":670578200},{"date":"2022-08-26","current":-8.900001,"twenty":-31.060738,"median":-21.271169,"eighty":-8.011017,"marketCap":744992395},{"date":"2022-09-02","current":-8.519008,"twenty":-31.060738,"median":-21.138357,"eighty":-8.011017,"marketCap":713100597},{"date":"2022-09-09","current":-7.995777,"twenty":-30.933616,"median":-21.105538,"eighty":-7.999841,"marketCap":669302528},{"date":"2022-09-16","current":-6.959476,"twenty":-30.789242,"median":-21.059141,"eighty":-7.923606,"marketCap":582556838},{"date":"2022-09-23","current":-5.994293,"twenty":-30.708473,"median":-20.979902,"eighty":-7.868404,"marketCap":501764284},{"date":"2022-09-30","current":-5.450743,"twenty":-30.687234,"median":-20.941849,"eighty":-7.712605,"marketCap":456265319},{"date":"2022-10-07","current":-5.928254,"twenty":-30.248198,"median":-20.833591,"eighty":-7.663406,"marketCap":496236372},{"date":"2022-10-14","current":-4.805594,"twenty":-30.046144,"median":-20.688162,"eighty":-7.541578,"marketCap":402261875},{"date":"2022-10-21","current":-4.866553,"twenty":-29.876776,"median":-20.623179,"eighty":-7.426779,"marketCap":407364563},{"date":"2022-10-28","current":-5.58282,"twenty":-29.653636,"median":-20.544719,"eighty":-7.358837,"marketCap":467321143},{"date":"2022-11-04","current":-4.937613,"twenty":-29.080284,"median":-20.48386,"eighty":-7.315495,"marketCap":425765440},{"date":"2022-11-11","current":-5.461,"twenty":-28.890141,"median":-20.44443,"eighty":-7.245997,"marketCap":470896576},{"date":"2022-11-18","current":-4.917863,"twenty":-28.790634,"median":-20.418018,"eighty":-7.170442,"marketCap":424062378},{"date":"2022-11-25","current":-4.962301,"twenty":-28.586668,"median":-20.202986,"eighty":-7.119868,"marketCap":427894267},{"date":"2022-12-02","current":-5.535064,"twenty":-27.910855,"median":-20.063714,"eighty":-6.936342,"marketCap":477283058},{"date":"2022-12-09","current":-5.061053,"twenty":-27.424926,"median":-20.005421,"eighty":-6.697713,"marketCap":436409576},{"date":"2022-12-16","current":-4.858611,"twenty":-27.33249,"median":-19.927101,"eighty":-6.50027,"marketCap":418953192},{"date":"2022-12-23","current":-4.172283,"twenty":-27.322692,"median":-19.850931,"eighty":-6.346106,"marketCap":359771796},{"date":"2022-12-30","current":-3.964903,"twenty":-27.297761,"median":-19.675794,"eighty":-6.100143,"marketCap":341889648},{"date":"2023-01-06","current":-3.614333,"twenty":-27.233308,"median":-19.571939,"eighty":-5.999776,"marketCap":311660302},{"date":"2023-01-13","current":-4.715421,"twenty":-27.102868,"median":-19.445096,"eighty":-5.92927,"marketCap":406605995},{"date":"2023-01-20","current":-4.878362,"twenty":-27.014024,"median":-19.292884,"eighty":-5.826656,"marketCap":420656254},{"date":"2023-01-27","current":-5.283246,"twenty":-26.892835,"median":-19.108961,"eighty":-5.735466,"marketCap":455569020},{"date":"2023-02-03","current":-5.075866,"twenty":-26.805797,"median":-19.033605,"eighty":-5.670788,"marketCap":437686872},{"date":"2023-02-10","current":-4.67592,"twenty":-26.777,"median":-18.95675,"eighty":-5.572661,"marketCap":403199871},{"date":"2023-02-17","current":-4.508041,"twenty":-26.536833,"median":-18.43559,"eighty":-5.491629,"marketCap":388723846},{"date":"2023-02-24","current":-4.03403,"twenty":-26.491026,"median":-18.411322,"eighty":-5.454807,"marketCap":347850364},{"date":"2023-03-03","current":-3.967704,"twenty":-26.346308,"median":-17.409962,"eighty":-5.383973,"marketCap":363064797},{"date":"2023-03-10","current":-3.621874,"twenty":-26.305094,"median":-15.895633,"eighty":-5.348916,"marketCap":331419574},{"date":"2023-03-17","current":-3.89293,"twenty":-26.302995,"median":-15.323339,"eighty":-5.282202,"marketCap":356222587},{"date":"2023-03-24","current":-4.710773,"twenty":-26.269237,"median":-15.259036,"eighty":-5.259705,"marketCap":431059265},{"date":"2023-03-31","current":-4.640672,"twenty":-26.142517,"median":-14.802487,"eighty":-5.212527,"marketCap":424644692},{"date":"2023-04-06","current":-4.687406,"twenty":-26.112945,"median":-14.516339,"eighty":-5.172644,"marketCap":428921074},{"date":"2023-04-14","current":-4.650019,"twenty":-26.108037,"median":-14.210901,"eighty":-5.13552,"marketCap":425499969},{"date":"2023-04-21","current":-4.702602,"twenty":-26.034281,"median":-14.000584,"eighty":-5.100554,"marketCap":430311589},{"date":"2023-04-28","current":-4.003901,"twenty":-25.949497,"median":-12.944138,"eighty":-5.066979,"marketCap":366376990},{"date":"2023-05-05","current":-3.860197,"twenty":-25.899314,"median":-12.41364,"eighty":-5.027642,"marketCap":353227321},{"date":"2023-05-12","current":-4.221936,"twenty":-25.874327,"median":-11.696665,"eighty":-4.992731,"marketCap":386328213},{"date":"2023-05-19","current":-4.038352,"twenty":-25.860445,"median":-11.301203,"eighty":-4.973529,"marketCap":381793844},{"date":"2023-05-26","current":-3.609508,"twenty":-25.82574,"median":-10.590658,"eighty":-4.94171,"marketCap":341250151},{"date":"2023-06-02","current":-3.662589,"twenty":-25.792424,"median":-10.195378,"eighty":-4.928812,"marketCap":346268536},{"date":"2023-06-09","current":-3.88939,"twenty":-25.766119,"median":-10.127679,"eighty":-4.917938,"marketCap":367710724},{"date":"2023-06-16","current":-3.884565,"twenty":-25.741345,"median":-10.052664,"eighty":-4.882277,"marketCap":367254507},{"date":"2023-06-23","current":-3.855611,"twenty":-25.729956,"median":-9.975147,"eighty":-4.860321,"marketCap":364517207},{"date":"2023-06-30","current":-3.865262,"twenty":-25.68831,"median":-9.883328,"eighty":-4.843497,"marketCap":365429640},{"date":"2023-07-07","current":-4.50706,"twenty":-25.641112,"median":-9.786874,"eighty":-4.809026,"marketCap":426106472},{"date":"2023-07-14","current":-4.598745,"twenty":-25.592526,"median":-9.633378,"eighty":-4.782343,"marketCap":434774591},{"date":"2023-07-21","current":-4.323689,"twenty":-25.545328,"median":-9.568245,"eighty":-4.757465,"marketCap":408770234},{"date":"2023-07-28","current":-4.232004,"twenty":-25.466628,"median":-9.503942,"eighty":-4.729619,"marketCap":400102116},{"date":"2023-08-04","current":-4.022807,"twenty":-25.440145,"median":-9.388337,"eighty":-4.710773,"marketCap":409682668},{"date":"2023-08-11","current":-3.681895,"twenty":-25.432034,"median":-9.245435,"eighty":-4.688166,"marketCap":374964170},{"date":"2023-08-18","current":-3.776302,"twenty":-25.401721,"median":-9.083751,"eighty":-4.654779,"marketCap":384578636},{"date":"2023-08-25","current":-3.978604,"twenty":-25.372513,"median":-8.94572,"eighty":-4.641607,"marketCap":405181063},{"date":"2023-09-01","current":-4.068516,"twenty":-25.330924,"median":-8.900001,"eighty":-4.636419,"marketCap":414337697},{"date":"2023-09-08","current":-4.327013,"twenty":-25.2448,"median":-8.823802,"eighty":-4.625556,"marketCap":440663020},{"date":"2023-09-15","current":-4.459633,"twenty":-25.151083,"median":-8.628226,"eighty":-4.583749,"marketCap":454169056},{"date":"2023-09-22","current":-3.578496,"twenty":-25.127484,"median":-8.590844,"eighty":-4.535691,"marketCap":364434041},{"date":"2023-09-29","current":-3.367203,"twenty":-25.126096,"median":-8.569874,"eighty":-4.504686,"marketCap":342915950},{"date":"2023-10-05","current":-2.980582,"twenty":-25.120873,"median":-8.516046,"eighty":-4.495545,"marketCap":303542423},{"date":"2023-10-13","current":-2.643412,"twenty":-25.099979,"median":-8.503483,"eighty":-4.449063,"marketCap":269205045},{"date":"2023-10-20","current":-2.589464,"twenty":-25.07647,"median":-8.433573,"eighty":-4.424101,"marketCap":263711064},{"date":"2023-10-27","current":-2.454597,"twenty":-25.070096,"median":-8.305342,"eighty":-4.40715,"marketCap":249976113},{"date":"2023-11-03","current":-2.331119,"twenty":-25.031232,"median":-8.23908,"eighty":-4.384974,"marketCap":272409867},{"date":"2023-11-10","current":-2.860235,"twenty":-24.967844,"median":-8.178654,"eighty":-4.360655,"marketCap":334241289},{"date":"2023-11-17","current":-2.99795,"twenty":-24.935916,"median":-8.087566,"eighty":-4.33487,"marketCap":350334388},{"date":"2023-11-24","current":-3.416391,"twenty":-24.919257,"median":-8.021273,"eighty":-4.319829,"marketCap":399232650},{"date":"2023-11-30","current":-3.140961,"twenty":-24.869283,"median":-8.010263,"eighty":-4.284305,"marketCap":367046452},{"date":"2023-12-08","current":-3.167445,"twenty":-24.869035,"median":-7.995777,"eighty":-4.24834,"marketCap":370141279},{"date":"2023-12-15","current":-4.089076,"twenty":-24.863581,"median":-7.936345,"eighty":-4.242148,"marketCap":477841250},{"date":"2023-12-22","current":-4.247978,"twenty":-24.855401,"median":-7.924659,"eighty":-4.234853,"marketCap":496410210},{"date":"2023-12-29","current":-4.804135,"twenty":-24.826249,"median":-7.919395,"eighty":-4.237551,"marketCap":561401572},{"date":"2024-01-05","current":-5.090158,"twenty":-24.806399,"median":-7.891216,"eighty":-4.240749,"marketCap":594825701},{"date":"2024-01-12","current":-4.534001,"twenty":-24.788662,"median":-7.830918,"eighty":-4.246673,"marketCap":529834339},{"date":"2024-01-19","current":-4.306242,"twenty":-24.724348,"median":-7.748919,"eighty":-4.247978,"marketCap":503218829},{"date":"2024-01-26","current":-5.275544,"twenty":-24.723524,"median":-7.704991,"eighty":-4.24834,"marketCap":616489488},{"date":"2024-02-02","current":-6.006493,"twenty":-24.676719,"median":-7.672777,"eighty":-4.253275,"marketCap":701906706},{"date":"2024-02-09","current":-5.874074,"twenty":-24.626351,"median":-7.586851,"eighty":-4.256543,"marketCap":686432573},{"date":"2024-02-16","current":-5.625128,"twenty":-24.461104,"median":-7.508778,"eighty":-4.256623,"marketCap":657341201},{"date":"2024-02-23","current":-5.302027,"twenty":-24.412573,"median":-7.436987,"eighty":-4.257189,"marketCap":619584315},{"date":"2024-03-01","current":-5.365997,"twenty":-24.364612,"median":-7.40628,"eighty":-4.27891,"marketCap":635677414},{"date":"2024-03-08","current":-6.115653,"twenty":-24.318085,"median":-7.362351,"eighty":-4.285539,"marketCap":724484744},{"date":"2024-03-15","current":-5.310534,"twenty":-24.308693,"median":-7.335994,"eighty":-4.292958,"marketCap":629107098},{"date":"2024-03-22","current":-5.150594,"twenty":-24.307394,"median":-7.292066,"eighty":-4.303941,"marketCap":610160024},{"date":"2024-03-28","current":-5.150594,"twenty":-24.277917,"median":-7.274495,"eighty":-4.313815,"marketCap":610160024},{"date":"2024-04-05","current":-5.653674,"twenty":-24.245989,"median":-7.239353,"eighty":-4.321759,"marketCap":669756833},{"date":"2024-04-12","current":-5.295993,"twenty":-24.233495,"median":-7.174925,"eighty":-4.323689,"marketCap":627384462},{"date":"2024-04-19","current":-4.857544,"twenty":-24.230719,"median":-7.122211,"eighty":-4.325683,"marketCap":575444136},{"date":"2024-04-26","current":-4.534477,"twenty":-24.208949,"median":-7.116354,"eighty":-4.336797,"marketCap":537172317},{"date":"2024-05-03","current":-4.75947,"twenty":-24.153737,"median":-6.930559,"eighty":-4.345321,"marketCap":563825905},{"date":"2024-05-10","current":-4.508898,"twenty":-24.117002,"median":-6.868037,"eighty":-4.349837,"marketCap":583645240},{"date":"2024-05-17","current":-4.218512,"twenty":-24.095216,"median":-6.645765,"eighty":-4.325683,"marketCap":546056846},{"date":"2024-05-24","current":-3.938686,"twenty":-24.023503,"median":-6.541187,"eighty":-4.310625,"marketCap":509835303},{"date":"2024-05-31","current":-3.919764,"twenty":-23.979081,"median":-6.472277,"eighty":-4.286368,"marketCap":507385958},{"date":"2024-06-07","current":-3.650346,"twenty":-23.9628,"median":-6.379513,"eighty":-4.256575,"marketCap":472511721},{"date":"2024-06-14","current":-3.666194,"twenty":-23.940589,"median":-6.2711,"eighty":-4.24805,"marketCap":474563147},{"date":"2024-06-21","current":-3.338667,"twenty":-23.918378,"median":-6.136252,"eighty":-4.234853,"marketCap":432167016},{"date":"2024-06-28","current":-3.164337,"twenty":-23.898943,"median":-6.111088,"eighty":-4.231722,"marketCap":409601333},{"date":"2024-07-05","current":-3.312253,"twenty":-23.867015,"median":-6.088269,"eighty":-4.219197,"marketCap":428747973},{"date":"2024-07-12","current":-3.81411,"twenty":-23.855547,"median":-6.064115,"eighty":-4.19235,"marketCap":493709787},{"date":"2024-07-15","current":-3.682042,"twenty":-23.855185,"median":-6.042912,"eighty":-4.185814,"marketCap":476614573},{"date":"2024-08-02","current":-3.379525,"twenty":-23.854822,"median":-6.021709,"eighty":-4.178462,"marketCap":470460296},{"date":"2024-08-09","current":-3.438839,"twenty":-23.770228,"median":-6.002352,"eighty":-4.160433,"marketCap":478717358},{"date":"2024-08-16","current":-3.463402,"twenty":-23.707022,"median":-5.980009,"eighty":-4.137439,"marketCap":482136767},{"date":"2024-08-23","current":-3.414276,"twenty":-23.635815,"median":-5.951375,"eighty":-4.121564,"marketCap":475297948},{"date":"2024-08-30","current":-3.753247,"twenty":-23.571105,"median":-5.928254,"eighty":-4.096495,"marketCap":522485802},{"date":"2024-09-06","current":-3.303742,"twenty":-23.549122,"median":-5.915051,"eighty":-4.093275,"marketCap":459910604},{"date":"2024-09-13","current":-3.330761,"twenty":-23.518168,"median":-5.883719,"eighty":-4.077035,"marketCap":463671955},{"date":"2024-09-20","current":-3.635344,"twenty":-23.483951,"median":-5.8317,"eighty":-4.057263,"marketCap":506072635},{"date":"2024-09-27","current":-3.394625,"twenty":-23.461814,"median":-5.816866,"eighty":-4.04273,"marketCap":472562420},{"date":"2024-10-04","current":-2.893538,"twenty":-23.419548,"median":-5.784931,"eighty":-4.033143,"marketCap":402806462},{"date":"2024-10-11","current":-3.210814,"twenty":-23.375321,"median":-5.773006,"eighty":-4.018034,"marketCap":446974181},{"date":"2024-10-18","current":-3.327571,"twenty":-23.362174,"median":-5.724864,"eighty":-4.003901,"marketCap":463227788},{"date":"2024-10-25","current":-3.158819,"twenty":-23.351229,"median":-5.671322,"eighty":-3.984808,"marketCap":439736087},{"date":"2024-10-31","current":-3.040916,"twenty":-23.325624,"median":-5.666497,"eighty":-3.974585,"marketCap":423322920},{"date":"2024-11-08","current":-2.512648,"twenty":-23.278426,"median":-5.653674,"eighty":-3.956629,"marketCap":362630335},{"date":"2024-11-15","current":-2.318273,"twenty":-23.238065,"median":-5.625128,"eighty":-3.946791,"marketCap":334577800},{"date":"2024-11-22","current":-2.109676,"twenty":-23.2086,"median":-5.595983,"eighty":-3.936227,"marketCap":304472640},{"date":"2024-11-29","current":-2.178418,"twenty":-23.203464,"median":-5.58282,"eighty":-3.928126,"marketCap":314393658},{"date":"2024-12-06","current":-1.941376,"twenty":-23.14898,"median":-5.572161,"eighty":-3.898633,"marketCap":280183249},{"date":"2024-12-13","current":-2.090712,"twenty":-23.050764,"median":-5.535064,"eighty":-3.884565,"marketCap":301735807},{"date":"2024-12-20","current":-1.858411,"twenty":-23.029941,"median":-5.510712,"eighty":-3.871089,"marketCap":268209606},{"date":"2024-12-27","current":-1.96271,"twenty":-22.977767,"median":-5.491629,"eighty":-3.85928,"marketCap":283262186},{"date":"2025-01-03","current":-1.967451,"twenty":-22.958044,"median":-5.478372,"eighty":-3.84445,"marketCap":283946394},{"date":"2025-01-10","current":-1.96271,"twenty":-22.895287,"median":-5.463613,"eighty":-3.822364,"marketCap":283262186},{"date":"2025-01-17","current":-1.616628,"twenty":-22.800914,"median":-5.451757,"eighty":-3.80253,"marketCap":233314989},{"date":"2025-01-24","current":-1.834707,"twenty":-22.78428,"median":-5.410103,"eighty":-3.786475,"marketCap":264788565},{"date":"2025-01-31","current":-1.976932,"twenty":-22.758743,"median":-5.392152,"eighty":-3.765188,"marketCap":285314811},{"date":"2025-02-07","current":-2.195011,"twenty":-22.756201,"median":-5.372123,"eighty":-3.713614,"marketCap":316788387},{"date":"2025-02-14","current":-2.095453,"twenty":-22.749211,"median":-5.366729,"eighty":-3.683942,"marketCap":302420015},{"date":"2025-02-21","current":-2.907785,"twenty":-22.729764,"median":-5.355767,"eighty":-3.674645,"marketCap":419657378},{"date":"2025-02-28","current":-2.335886,"twenty":-22.724541,"median":-5.310534,"eighty":-3.663709,"marketCap":362347340},{"date":"2025-03-07","current":-2.401632,"twenty":-22.662073,"median":-5.302214,"eighty":-3.650346,"marketCap":372545990},{"date":"2025-03-14","current":-2.084999,"twenty":-22.648191,"median":-5.293121,"eighty":-3.614333,"marketCap":323429230},{"date":"2025-03-21","current":-1.771353,"twenty":-22.602406,"median":-5.285716,"eighty":-3.609508,"marketCap":274775836},{"date":"2025-03-28","current":-1.846031,"twenty":-22.583904,"median":-5.275544,"eighty":-3.583341,"marketCap":286359977},{"date":"2025-04-04","current":-1.690701,"twenty":-22.486664,"median":-5.266345,"eighty":-3.549373,"marketCap":262264963},{"date":"2025-04-11","current":-1.613037,"twenty":-22.44808,"median":-5.254357,"eighty":-3.537092,"marketCap":250217456},{"date":"2025-04-17","current":-1.786289,"twenty":-22.413708,"median":-5.238807,"eighty":-3.510163,"marketCap":277092664},{"date":"2025-04-25","current":-2.38371,"twenty":-22.382839,"median":-5.217173,"eighty":-3.467332,"marketCap":369765796},{"date":"2025-05-02","current":-2.449426,"twenty":-22.348098,"median":-5.189483,"eighty":-3.45849,"marketCap":379959841},{"date":"2025-05-09","current":-2.533503,"twenty":-22.189991,"median":-5.17215,"eighty":-3.437999,"marketCap":349114123},{"date":"2025-05-16","current":-2.681942,"twenty":-22.113484,"median":-5.16686,"eighty":-3.418629,"marketCap":369568924},{"date":"2025-05-23","current":-2.838106,"twenty":-22.094059,"median":-5.150594,"eighty":-3.402916,"marketCap":391088127},{"date":"2025-05-30","current":-2.810947,"twenty":-22.062712,"median":-5.141116,"eighty":-3.382835,"marketCap":387345657},{"date":"2025-06-06","current":-3.075746,"twenty":-21.965994,"median":-5.125242,"eighty":-3.366382,"marketCap":423834741},{"date":"2025-06-13","current":-3.068956,"twenty":-21.890236,"median":-5.100554,"eighty":-3.345499,"marketCap":422899123},{"date":"2025-06-20","current":-3.259069,"twenty":-21.8639,"median":-5.087949,"eighty":-3.333014,"marketCap":449096414},{"date":"2025-06-27","current":-1.806067,"twenty":-21.841236,"median":-5.070929,"eighty":-3.324388,"marketCap":248874262},{"date":"2025-07-03","current":-2.213451,"twenty":-21.82892,"median":-5.061053,"eighty":-3.312253,"marketCap":305011314},{"date":"2025-07-11","current":-2.525778,"twenty":-21.813263,"median":-5.046912,"eighty":-3.26231,"marketCap":348049721},{"date":"2025-07-18","current":-2.634414,"twenty":-21.769612,"median":-5.014557,"eighty":-3.235121,"marketCap":363019601},{"date":"2025-07-25","current":-2.967111,"twenty":-21.757367,"median":-5.000409,"eighty":-3.210018,"marketCap":408864860},{"date":"2025-07-30","current":-2.912793,"twenty":-21.757367,"median":-4.996002,"eighty":-3.203658,"marketCap":401379920}],"updateTime":1754007275031}}}